SCHEMBL26565176

SCHEMBL26565176

Clc1cc(Cl)cc(-c2ccc3cc(-c4ccc(-c5cccc6c5oc5ccccc56)nc4)ccc3c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
AHR P35869 2/20 0.34
PRKDC P78527 3/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
CYP1A2 P05177 2/20 0.33
GGPS1 O95749 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CLK1 P49759 1/20 0.33
PDCD1LG2 Q9BQ51 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17212568 0.92 ALOX5 (0.49) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL17212576 0.88 ALOX5 (0.48) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL19933653 0.86 ALOX5 (0.49) ALOX5AHRPRKDCPIK3CDPIK3CB
SCHEMBL26565249 0.86 PIK3CA (0.36) PRKDCCYP1A2CYP1A1CYP1B1PDCD1LG2
SCHEMBL26551827 0.85 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBLMNA
SCHEMBL26548247 0.85 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBCYP1A2
SCHEMBL26565106 0.85 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBCYP1A2
SCHEMBL26551836 0.85 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBMAPT
SCHEMBL17212563 0.84 ALOX5 (0.51) ALOX5AHRPRKDCPIK3CDPIK3CB
SCHEMBL26548255 0.84 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 ALOX5 1577/4885AHR 4174/4885PRKDC 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.